The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your ...
On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...
AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...
AstraZeneca’s new U.S. spending also leaves in doubt the pharmaceutical company’s plans to invest in a vaccine site in ...
The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...
GlobalData on MSN22h
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccineNovavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...
The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback